Quantcast

Latest Amyotrophic lateral sclerosis Stories

2014-10-22 12:29:36

WASHINGTON, Oct. 22, 2014 /PRNewswire-USNewswire/ -- ALS ACT, The ALS Association, and the Translational Research Advancing Therapy ALS (TREAT ALS(TM)) Northeast ALS Consortium (NEALS) clinical trials network are pleased to announce a call for phase II clinical trial applications for novel, high-potential treatments in amyotrophic lateral sclerosis (ALS). The call for clinical study proposals is directed toward academic-industry partnerships, including pharmaceutical,...

2014-10-21 12:25:21

Local CITGO Marketer Sponsors MDA Toast to Life Gala APPLETON, Wis., Oct. 21, 2014 /PRNewswire/ -- Local CITGO Marketer Garrow Oil Corporation and CITGO Petroleum Corporation are teaming up to sponsor the inaugural MDA Toast to Life Gala to benefit ALS research and to honor Jane Vanden Heuvel of Little Chute, who was diagnosed with ALS in 2011. On Oct. 23, guests are invited to the Timber Rattlers Banquet Venue at Fox Cities Stadium in Appleton to participate in the event. "Hosting...

2014-10-16 08:30:19

LOS ANGELES, Oct. 16, 2014 /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that its Board of Directors has appointed Steven A. Kriegsman, President, Chief Executive Officer and a Director of the Company, as Chairman of the Board, effective October 15, 2014. He replaces Max E. Link, Ph.D. whose unexpected passing was announced on October 7, 2014. "I am honored to assume the additional...

2014-10-13 08:26:19

Expected to Yield First Clinical Candidate in 2015 LOS ANGELES, Oct. 13, 2014 /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that it has commenced operations at its new discovery laboratory, located in Freiburg, Germany. The new laboratory will conduct discovery and translational research to create drug candidates that utilize novel linker technologies that couple chemotherapeutic...

2014-10-09 08:28:44

NSI-566 to be Tested in Four Patients with Chronic Spinal Cord Injury GERMANTOWN, Md., Oct. 9, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that the first patient was treated last week in the Phase I trial testing NSI-566 human neural stem cells in the treatment of chronic spinal cord injury (cSCI) at the UC San Diego School of Medicine. The patient has been discharged from the hospital. The NSI-566/cSCI Phase I trial will treat four patients who have thoracic spinal...

2014-10-08 08:27:11

ALISO VIEJO, Calif., Oct. 8, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that data from the phase II trial evaluating AVP-923 for the treatment of agitation in patients with Alzheimer's disease (AD) and the results of the phase IV PRISM II study evaluating NUEDEXTA® (dextromethorphan hydrobromide/quinidine sulfate) for the treatment of pseudobulbar affect (PBA) in patients with AD will be presented at the American Neurological Association's (ANA)...

2014-10-07 16:27:01

LOS ANGELES, Oct. 7, 2014 /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced Max E. Link, Ph.D., Chairman of the Board of Directors, passed away unexpectedly at the age of 74. "We are deeply saddened by the loss of our dear friend and colleague, and our thoughts are with his family during this difficult time," said Steven A. Kriegsman, CytRx President and Chief Executive Officer. "Max was a...

2014-10-06 08:29:34

NEW YORK and PETACH TIKVAH, Israel, Oct. 6, 2014 /PRNewswire/ -- BrainStorm Cell Therapeutics (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that the last patient has completed the last visit in its phase 2a clinical trial of NurOwn(TM) in Amyotrophic Lateral Sclerosis (ALS), conducted at the Hadassah Medical Center in Jerusalem. The company expects to release final results of the study in the fourth quarter of 2014...

2014-10-02 12:31:07

Additional $12.5 Million in Matching Gifts Bring Total Commitment to $34.2 million WASHINGTON, Oct. 2, 2014 /PRNewswire-USNewswire/ -- After the generous outpouring of support from people all around the globe due to this summer's Ice Bucket Challenge, the Board of Trustees of The ALS Association has approved an initial expenditure of $21.7 million in funding to support six programs and initiatives to expedite the search for treatments and a cure for amyotrophic lateral sclerosis...

2014-09-30 23:14:17

New video from the National Hospice and Palliative Care Organization's “Moments of Life” campaign shows the compassion provided by hospice to a couple facing ALS. Alexandria, VA (PRWEB) September 30, 2014 Visit Pam and Steve’s quiet home in the Philadelphia neighborhood of Chestnut Hill and you will find a loving couple facing the most monumental challenge of their life together, Amyotrophic Lateral Sclerosis. Steve was diagnosed with ALS – more commonly known as ALS or Lou...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related